| Literature DB >> 25435421 |
Reibin Tai, Yasushi Ohashi1, Sonoo Mizuiri, Atsushi Aikawa, Ken Sakai.
Abstract
BACKGROUND: Excess extracellular volume is a major clinical problem in patients with chronic kidney disease (CKD). However, whether the extracellular volume status is associated with disease progression is unclear. We investigated the association between the extracellular volume status and renal outcomes.Entities:
Mesh:
Substances:
Year: 2014 PMID: 25435421 PMCID: PMC4268815 DOI: 10.1186/1471-2369-15-189
Source DB: PubMed Journal: BMC Nephrol ISSN: 1471-2369 Impact factor: 2.388
Figure 1Associations between extracellular volume status and actual values of body composition (A in men and B in women) and percentages of fluid volume in body weight (C in men and D in women). Abbreviations: BW, body weight; ECWBIA, extracellular water as measured by electrical bioimpedance analysis; ECWPeters, extracellular water calculated using the Peters formula; TBWWatson, total body water calculated using the Watson formula.
Figure 2Correlations between age with an imbalance between ICW and ECW. Abbreviations: ICWBIA, intracellular water; ECWBIA, extracellular water; TBWBIA, total body water as measured by bioimpedance analysis.
Patients characteristics separated by tertiles of the percentage of ECW to TBW
| Population characteristics | Percentage of ECW BIAto TBW Watson |
| ||
|---|---|---|---|---|
| Tertile 1 ( | Tertile 2 ( | Tertile 3 ( | ||
| Age, years | 62.0 ± 16.6 | 61.8 ± 15.1 | 67.1 ± 16.4 | 0.18 |
| Height, cm | 159 ± 10 | 159 ± 11 | 161 ± 8 | 0.46 |
| Weight, kg | 61 ± 15 | 56 ± 12 | 56 ± 10 | 0.09 |
| Body surface area, m2 | 1.62 ± 0.21 | 1.56 ± 0.21 | 1.58 ± 0.16 | 0.41 |
| Body mass index, kg/m2 | 24.0 ± 4.2 | 22.0 ± 3.5 | 21.6 ± 2.9 | <0.01 |
|
| ||||
| Glomerulonephritis, | 23 (46.0) | 22 (45.0) | 17 (34.0) | 0.41 |
| Diabetes mellitus, | 4 (8.0) | 7 (14.3) | 13 (26.0) | <0.05 |
| Nephrosclerosis, | 9 (18.0) | 10 (20.4) | 9 (18.0) | 0.94 |
| ADPKD, | 0 (0.0) | 0 (0.0) | 1 (2.0) | 0.37 |
| Others, | 14 (28.0) | 10 (20.4) | 10 (20.0) | 0.56 |
| Systolic blood pressure, mmHg | 127 ± 19 | 122 ± 17 | 129 ± 21 | 0.19 |
| Diastolic blood pressure, mmHg | 75 ± 11 | 71 ± 9 | 69 ± 10 | <0.01 |
| Pulse pressure, mmHg | 52 ± 11 | 51 ± 13 | 60 ± 17 | <0.01 |
| Resistant high blood pressure, | 6 (12.0) | 12 (24.5) | 19 (38.0) | <0.05 |
| TBWBIA, L (% in BW) | 30.1 ± 7.5 | 30.9 ± 7.2 | 32.7 ± 5.6 | 0.14 |
| (49.6 ± 5.6) | (55.3 ± 5.6) | (58.7 ± 5.1) | (<0.001) | |
| ICWBIA, L (% in BW) | 18.4 ± 4.7 | 18.8 ± 4.6 | 19.7 ± 3.4 | 0.30 |
| (30.2 ± 3.5) | (33.5 ± 3.8) | (35.2 ± 3.2) | (<0.001) | |
| ECWBIA, L (% in BW) | 11.7 ± 2.8 | 12.1 ± 2.6 | 13.1 ± 2.2 | 0.02 |
| (19.3 ± 2.1) | (21.7 ± 2.0) | (23.4 ± 2.1) | (<0.001) | |
| Serum creatinine, mg/dL | 1.67 ± 1.17 | 1.76 ± 1.27 | 2.55 ± 1.78 | <0.01 |
| eGFRCKD-EPI, ml/min per 1.73 m2 | 71.7 ± 48.8 | 71.0 ± 52.7 | 48.9 ± 46.2 | <0.05 |
| Serum albumin, g/dL | 4.1 ± 0.4 | 4.0 ± 0.4 | 3.7 ± 0.5 | <0.001 |
| Total cholesterol, mg/dL | 200 ± 34 | 193 ± 36 | 191 ± 55 | 0.53 |
| Triglycerides, mg/dL | 147 ± 71 | 139 ± 95 | 129 ± 88 | 0.55 |
| Fasting blood glucose, mg/dL | 103 ± 19 | 132 ± 45 | 134 ± 42 | <0.05 |
| UPCR, g/g · Cr | 0.9 ± 1.5 | 0.8 ± 1.3 | 1.6 ± 1.9 | <0.05 |
| Uric acid, >7.0 mg/dL in men or >6.0 mg/dL in women, | 23 (46.9) | 27 (55.1) | 32 (64.0) | 0.23 |
| 24-hour urinary urea nitrogen excretion, g/day | 2.1 ± 1.0 | 2.5 ± 1.9 | 2.2 ± 1.5 | 0.40 |
| 24-hour urinary creatinine excretion, g/day | 1.5 ± 1.1 | 1.6 ± 1.5 | 1.5 ± 0.8 | 0.81 |
| 24-hour urinary sodium excretion, mmol/day | 143 ± 58 | 128 ± 50 | 130 ± 54 | 0.37 |
| Furosemide, | 5 (10.0) | 6 (12.2) | 18 (36.0) | <0.01 |
| Other diuretics, | 7 (14.0) | 7 (14.3) | 6 (12.0) | 0.94 |
| ACE inhibitors, | 14 (28.0) | 17 (34.7) | 16 (32.0) | 0.77 |
| AT1-R blockers, | 30 (60.0) | 28 (57.1) | 25 (50.0) | 0.58 |
| Other antihypertensives | 20 (40.0) | 25 (51.0) | 31 (62.0) | 0.09 |
Abbreviations: TBW total body water as measured by bioimpedance analysis, ICW intracellular water as measured by bioimpedance analysis, ECW extracellular water as measured by bioimpedance analysis, TBW total body water calculated using the Watson formula, eGFR estimated glomerular filtration rate using the Chronic Kidney Disease Epidemiology Collaboration equation, UPCR urinary protein-to-creatinine ratio, ACE inhibitors angiotensin-converting enzyme inhibitors, AT1-receptor blockers angiotensin II type 1 receptor blockers.
Independent factors associated with the percentage of ECW to TBW
| Variables | Univariate analysis | Multivariate analysis* | ||
|---|---|---|---|---|
| ß (95% CI) |
| ß (95% CI) |
| |
| Age, per 10 years of age | 0.18 (0.04–0.72) | 0.03 | 0.01 (-0.40–0.44) | 0.94 |
| Men | 0.21 (0.17–1.27) | 0.01 | 0.18 (0.04–1.16) | 0.04 |
| Diabetes mellitus | 0.30 (0.67–2.13) | <0.001 | 0.11 (-0.31–1.31) | 0.23 |
| eGFRCKD-EPI, ml/min per 1.73 m2 | -0.24 (-5.71 to -1.11) | 0.01 | -0.05 (-0.02–0.01) | 0.63 |
| UPCR, g/g · Cr | 0.32 (0.33–0.96) | <0.001 | 0.17 (0.20–0.87) | 0.01 |
Note: *Significant factors associated with the percentage of extracellular water volume as measured by bioimpedance analysis to total body water volume calculated by the Watson formula identified in the univariate analysis (P < 0.10) were subjected to multivariable analysis. When the eGFR calculated by the revised formula for Japanese patients based on the Modification of Diet in Renal Disease method was used as the dependent variable instead of eGFRCKD-EPI, the results remained similar (data not shown). Additionally, when the serum albumin level was used as the dependent variable instead of UPCR, the independent factors were sex, diabetes mellitus, and serum albumin (data not shown).
Abbreviations: ECW extracellular water as measured by bioimpedance analysis, TBW total body water calculated using the Watson formula, eGFR estimated glomerular filtration rate using the Chronic Kidney Disease Epidemiology Collaboration equation, UPCR urinary protein-to-creatinine ratio, β standardized regression coefficient, CI confidence interval.
Figure 3Kaplan–Meier survival curves for adverse renal outcomes by tertiles of %ECW /TBW .
Hazard ratios of different clinical variables for adverse renal outcomes
| Variables | Univariate analysis | Multivariate analysis* | ||
|---|---|---|---|---|
| HR (95% CI) |
| HR (95% CI) |
| |
| Age, per 10 years of age | 1.03 (1.01–1.05) | 0.01 | 0.84 (0.69–1.04) | 0.10 |
| Men | 1.82 (1.04–3.29) | 0.04 | 1.13 (0.60–2.10) | 0.70 |
| Diabetes mellitus | 3.60 (1.90–6.50) | <0.001 | 1.49 (0.72–2.98) | 0.28 |
| %ECWBIA/TBWWatson | 1.24 (1.13–1.35) | <0.001 | 1.21 (1.10–1.34) | <0.001 |
| Systolic blood pressure, mmHg | 1.02 (1.01–1.04) | <0.001 | 1.00 (0.99–1.02) | 0.63 |
| Baseline eGFRCKD-EPI, ml/min/1.73 m2 | 0.92 (0.90–0.94) | <0.001 | 0.96 (0.95–0.98) | <0.001 |
| UPCR, g/gCr | 1.29 (1.15–1.42) | <0.001 | 1.20 (1.01–1.38) | 0.04 |
Note: *Adjusted for age, male sex, diabetes mellitus, systolic blood pressure, ECWBIA/TBWWatson percentage, baseline estimated glomerular filtration rate, and urinary protein–creatinine ratio (variables associated with adverse renal outcomes identified in the univariate analysis [P < 0.10] were entered into the multivariable model). When the ECWBIA/ECWPeters ratio was used as the dependent variable instead of the %ECWBIA/TBWWatson ratio, the results remained similar (data not shown).
Abbreviations: HR hazard ratio, CI confidence interval, %ECW /TBW percentage of extracellular water as measured by bioimpedance analysis to total body water calculated using the Watson formula, eGFR estimated glomerular filtration rate using the Chronic Kidney Disease Epidemiology Collaboration equation, UPCR urinary protein-to-creatinine ratio.
Figure 4Receiver operating characteristic curves in the assessment of %ECW /TBW as a prognostic factor of adverse renal outcomes in all patients, male patients, and female patients. Abbreviations: TBWBIA, total body water as measured by bioimpedance analysis; TBWWatson, total body water calculated using the Watson formula; AUC, area under the curve; CI, confidence interval.